Currently, Abbvie Inc [ABBV] is trading at $192.34, up 3.38%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ABBV shares have gain 13.03% over the last week, with a monthly amount drifted -5.12%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on April 22, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $210. On December 05, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $180 on the stock. Leerink Partners upgraded its rating to a Outperform but stick to its price target of $206 on November 22, 2024. Wolfe Research initiated its recommendation with a Outperform and recommended $205 as its price target on November 15, 2024. Argus upgraded its rating to Buy for this stock on November 04, 2024. In a note dated October 17, 2024, Bernstein initiated an Mkt Perform rating and provided a target price of $203 on this stock.
This stock has fluctuated between a low of $153.58 and a high of $218.66 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $217.75 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $192.34 at the most recent close of the market. An investor can expect a potential return of 13.21% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Trailing Twelve Months sales for Abbvie Inc [NYSE:ABBV] were 57.37B which represents 8.39% growth. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.7 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of20.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 188.94 points at the first support level, and at 185.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 194.43, and for the 2nd resistance point, it is at 196.52.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abbvie Inc [NYSE:ABBV] is 0.66. As well, the Quick Ratio is 0.55, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 5.93, the price to book ratio is 102.11 and price to earnings (TTM) ratio is 81.82.
Transactions by insiders
Recent insider trading involved Stewart Jeffrey Ryan, EVP, CHIEF COMMERCIAL OFFICER, that happened on Mar 31 ’25 when 58832.0 shares were sold. Officer, Stewart Jeffrey Ryan completed a deal on Mar 31 ’25 to buy 58832.0 shares. Meanwhile, EVP, CHIEF FINANCIAL OFFICER Reents Scott T sold 17644.0 shares on Mar 14 ’25.
